Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2-Reference-Cited by-同舟云学术

Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2

Published:2020-05 Issue:10 Volume:28 Page:115453
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Kuriwaki Ikumi,Kameda Minoru,Hisamichi Hiroyuki,Kikuchi Shigetoshi,Iikubo Kazuhiko,Kawamoto Yuichiro,Moritomo Hiroyuki,Kondoh Yutaka,Amano Yasushi,Tateishi Yukihiro,Echizen Yuka,Iwai Yoshinori,Noda Atsushi,Tomiyama Hiroshi,Suzuki Tomoyuki,Hirano Masaaki

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference33 articles.

1. The present and future burden of urinary bladder cancer in the world;Ploeg;World J Urol,2009

2. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;Maase;J Clin Oncol,2005

3. Bladder cancer;Bischoff;Curr Opin Oncol,2009

4. Immune checkpoint inhibitors for urothelial carcinoma;Kim;Investig Clin Urol,2018

5. Fibroblast growth factor signaling: from development to cancer;Turner;Nat Rev Cancer,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-based drug-development study against fibroblast growth factor receptor 2: molecular docking and Molecular dynamics simulation approaches;Scientific Reports;2024-08-21

2. Computational biophysical characterization of the effect of gatekeeper mutations on the binding of ponatinib to the FGFR kinase;Archives of Biochemistry and Biophysics;2024-08

3. Isovaleryl Sucrose Esters from Atractylodes japonica and Their Cytotoxic Activity;Molecules;2024-06-27

4. Active and machine learning-enhanced discovery of new FGFR3 inhibitor, Rhapontin, through virtual screening of receptor structures and anti-cancer activity assessment;Frontiers in Molecular Biosciences;2024-06-11

5. Advancement of Computational Design Drug Delivery System in COVID- 19: Current Updates and Future Crosstalk- A Critical Update;Infectious Disorders - Drug Targets;2023-12